U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07880678) titled 'Risk Stratification for Adverse Events in End-Stage Liver Disease' on Oct. 12.
Brief Summary: Study Goal The goal of this multicenter, prospective observational cohort study is to develop and validate a multimodal predictive model that integrates portal hypertension, inflammation, and liver function indicators to predict the risk of adverse clinical outcomes (e.g., further decompensation, mortality, recompensation, and liver failure) in patients with decompensated cirrhosis.
Target Population The study will enroll adults aged 18-80 years with chronic liver disease of any etiology who have experienced at least one decompensating eve...